Navigation Links
Pulmonary rehabilitation program effective for chronic obstructive pulmonary disease

A recent research paper on chronic obstructive pulmonary disease (COPD) said that pulmonary// rehabilitation programs are often useful for patients of this disease to have improved daily functions and activities.

Chronic obstructive pulmonary disease (COPD) are lung diseases involving restricted airflow and conditions like lung tissue destruction, airway inflammation, air sac enlargement etc. some common forms of COPD are emphysema and chronic bronchitis.

Pulmonary rehabilitation programs involve exercise training to improve functional capacity of the lungs, taking into consideration the cardiovascular, pulmonary and skeletal muscle limitations. Goals of these programs are to reduce the symptoms of the diseases, increase the physical abilities of the patients and restore the highest level of independence in the attending to the daily functions of the patients.

Researchers had said that by talking the six-minute walk test the patients who had undergone the rehabilitation program could improve on their ability by about 54 meters. The peak work rate of these patients had also improved by about 18% when compared to their physical state before they had undergone the program.

Reference: American Journal of Respiratory and Critical Care Medicine, July 2005
'"/>




Page: 1

Related medicine news :

1. FDA Approves Remodulin for Pulmonary Hypertension
2. Antipsychotic Drug Linked to Pulmonary Embolism
3. Treating Pulmonary Arterial Hypertension In Children With Viagra
4. CT Pulmonary Angiography Scan More Effective In Detecting Dangerous Blood Clots In The Legs
5. People Suffering From Chronic Pulmonary Disease To Get Relief From Harmonica
6. Risk Factors Can Identify Pulmonary Embolism
7. Hormone Can Foretell Presence Of Potentially Fatal Pulmonary Hypertension
8. Malfunction Of Key Growth Factor Increases Mortality Rate From Pulmonary Fibrosis In Blacks
9. Lesser Know Facts about Idiopathic Pulmonary Fibrosis (IPF)
10. Research Finds, Risk Of Pulmonary Disease Increases With Wrinkled Smokers
11. Pulmonary Hypertension Discriminates by Race, Gender
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2017)... ... 2017 , ... CareSet Labs released the Root NPI Graph today at the ... greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. , ... called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable ... that visits to the dentist fit into their patients’ busy lifestyles. Dental365 also ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... By ... earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ... the top 1% of all charities reviewed by Charity Navigator and earns ANRF a ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection friend ... entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger to ... years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class photographer, ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: